Patient 1
Sex: Female
Age: 11.6 years old
Medications: Prozac (however she was
taking this medication before, during, and after the neurofeedback sessions)
Diagnoses: ADHD, Depression
Neurofeedback sessions completed before
retest: 22 sessions
Test Type
|
iQ (Abstract/ Verbal)
|
Subject
|
Initial
|
Final
|
Change in Standard Deviation
|
Connors
|
104/80
|
Ommision Errors
|
34 blank
|
4 blank
|
|
|
|
Commision Errors
|
27 wrong
|
16 wrong
|
|
TOVA
|
104/80
|
Ommision Errors
|
57 blank
|
28 blank
|
|
|
|
Commision Errors
|
31 wrong
|
35 wrong
|
|
|
|
Omission Score
|
<40
|
<40
|
cannot be shown
|
|
|
Commision Score
|
81
|
75
|
-0.4
|
|
|
Response Time Score
|
71
|
93
|
1.46
|
|
|
RT Variability Score
|
<40
|
<40
|
cannot be shown
|
|
|
ADHD Score
|
-7.68
|
-7.51
|
|
The girl’s TOVA omission errors decreased by 29,
which is indicative of fast improvement. The patient’s commission errors
increased, but only by 4. On the whole, improvement seems likely. The omission
score stayed below 40 (this is the lowest score on the TOVA test). But we can
assume it increased from its initial value since her omission errors decreased
greatly. Her commission score decreased by 0.4 standard deviations, which was
caused by slightly increase amount of commission errors on the retest. Her
response time score increased by an astonishing 1.46 standard deviations.
Previously, her score was 71, which is indicative of a problem with an iQ score
of 104. However, it increased to 93, which is within the acceptable range. Her
ADHD score increased by 0.17. While this does not seem to be a vast improvement,
coupled with her other improvements, it is safe to assume that this patient has
made some progress with her neurofeedback sessions.
Patient 2
Sex: Male
Age: 47 years old
Medications: Mirax (however he was
taking this medication before, during, and after the neurofeedback sessions)
Diagnoses: severe ADHD, Depression
Neurofeedback sessions completed before
retest: 28 sessions
Test Type
|
iQ (Abstract/ Verbal)
|
Subject
|
Initial
|
Final
|
Change in Standard Deviation
|
TOVA
|
125/119
|
Ommision Errors
|
0
|
1
|
|
|
|
Commision Errors
|
12
|
5
|
|
|
|
Omission Score
|
101
|
86
|
-1
|
|
|
Commision Score
|
92
|
110
|
1.2
|
|
|
Response Time Score
|
82
|
83
|
0.0667
|
|
|
RT Variability Score
|
<40
|
56
|
1.0667
|
|
|
ADHD Score
|
-6.78
|
-5.1
|
|
While this patient’s omission errors increased from
0 to 1, his commission errors decreased from 12 to 5, which is a much more
significant change. The omission score decreased by 1 standard deviation. We
can see that, in fact, his omission errors only decreased by 1, so this is not
much of a concern. The commission score change reflects improvement, as it
increased by 1.2 s.d. The Response Time score stayed about the same. The
Variability score however increased from a point below 40 to 56, which is a minimum
improvement of 1.0667 s.d. This is vast improvement, so this patient has made
significant progress with his 28 sessions of neurofeedback therapy. To support
this, his ADHD score increased by 1.68. While this still is indicative of
severe ADD, the patient has made significant progress.
Patient 3
Sex: Male
Age: 45 years old
Medications: Vyvanse for ADHD (however he was taking this medication before, during, and after the neurofeedback sessions)
Diagnoses: slight ADHD, Attention/Impulsivity problems
Neurofeedback sessions completed before retest: 24 sessions
Test Type
|
iQ (Abstract/ Verbal)
|
Subject
|
Initial
|
Final
|
Change in Standard
Deviation
|
Connors
|
107/100
|
Ommision Errors
|
1
|
0
|
|
|
|
Commision Errors
|
2
|
3
|
|
TOVA
|
107/100
|
Ommision Errors
|
0
|
0
|
|
|
|
Commision Errors
|
4
|
1
|
|
|
|
Omission Score
|
101
|
101
|
0
|
|
|
Commision Score
|
112
|
120
|
0.533
|
|
|
Response Time Score
|
96
|
87
|
-0.6
|
|
|
RT Variability Score
|
109
|
112
|
0.2
|
|
|
ADHD Score
|
0.95
|
2.59
|
|
This patient’s number of errors decreased on the
whole. His omission score stayed the same while his commission score increased
by 0.533 standard deviations. It is important to understand that based on his
initial ADHD score, this patient did not have severe ADHD. So an improvement of
0.533 standard deviations is not negligible. However, the response time score
decreased by 0.6 standard deviations. On the whole this patient has made some
progress but not a significant amount. However, the change in his ADHD score of
+1.64 indicates vast progress.
Analysis
On the whole, all three patients made progress. I
administered each of their neurofeedback sessions from beginning to end, and
was able to watch their progress. Patients 2 and 3 in particular, according to
their TOVA retests, made the most progress and their ADHD scores increased by a
large amount. While patient 1’s progress was not as vast, it is clear that the
neurofeedback therapy made a difference: her scores, on the whole, increased,
and her ADHD scores proved progress.
Conclusion
Once again, I recognize that my data may not be as accurate as I had hoped since I only tested 3 patients. Confidentiality and patient protection laws prevented me from collecting more data. These 3 patients were the few that consented the use of their data for this project. However, since my internship Scottsdale Neurofeedback Institute was kind enough to share their own proven 94% success rate, I can see the validity of my results. While neurofeedback therapy may not be absolutely perfect, the majority of patients benefit from these sessions. All 3 of my patients improved greatly within even 25 sessions of neurofeedback. I conclude that my data is consistent with the already well established 94% success rate of Scottsdale Neurofeedback Institute. I acknowledge that neurofeedback therapy is quite effective at treating neurological problems (in this case, specifically ADHD), and decreasing attention/impulsivity problems, listening problems, etc. My patients’ cognitive functioning benefited greatly from the therapy.